Albemarle Corporation (NYSE: ALB) reported second-quarter 2026 net sales of $1.7 billion, a 31% increase year over year, driven by higher pricing in Energy Storage and Specialties.

Adjusted EBITDA more than doubled to $858 million, while the company generated $710 million in cash from operations, representing an operating cash conversion rate of more than 80%.

Financial Performance

The company’s strong top-line growth translated into significant earnings expansion. Net income attributable to Albemarle was $480 million, with diluted earnings per share of $3.52. The enterprise EBITDA margin expanded to 4.49%.

Segment Highlights

Energy Storage net sales increased 78% year over year, driven primarily by pricing. The segment delivered 65,000 tons of lithium carbonate equivalent (LCE) at an average realized price of approximately $20 per kg. This realized price was about 15% below market pricing due to the dilutive impact of spodumene sales and a three-month pricing lag in long-term agreements.

Specialties net sales rose 20% to $424 million, supported by higher pricing and volumes. Adjusted EBITDA for the segment grew 61% to $118 million, with margins expanding by 700 basis points to 28%. Management attributed this performance to favorable product mix resulting from bromine market disruptions linked to the situation in the Middle East.

What the Numbers Show

The divergence between segment profitability highlights the impact of external supply shocks. While Energy Storage drove volume and revenue growth through pricing power, the Specialties segment contributed disproportionately to margin expansion. The 700-basis-point margin increase in Specialties, driven by bromine pricing spikes, offset cost headwinds in Energy Storage where rising spodumene inventory costs and Chilean commission payments pressured gross margins despite higher sales prices.

Outlook and Operations

Albemarle raised its full-year 2026 outlook for Specialty sales to $1.4–$1.6 billion and adjusted EBITDA to $275–$325 million. The company expects to perform at the high end of its total company scenario ranges due to strong year-to-date performance.

Operational updates include:

• Restart of the CGP3 plant at Greenbushes on August 1, following a fire on June 9. Full run rate is now expected in Q1 2027.
• Better-than-planned production at Wodgina, offsetting some Greenbushes delays.
• Achievement of approximately $100 million in run-rate savings year to date, tracking toward the high end of the $100–$150 million full-year target.

Management noted that global lithium consumption rose 45% year over year through May, with stationary storage demand accelerating. Supply remains tight due to limited spodumene availability and slower-than-expected ramp-ups in Chinese lepidolite mines.

JPMorgan slashed its earnings and price targets for Albemarle Corp. (NYSE: ALB) amid falling lithium prices, triggering a 5.16% drop in shares to $134.21 on Tuesday.

Analyst Jeffrey Zekauskas maintained a Neutral rating but lowered the December 2027 price forecast to $140 from a previous December 2026 target of $160.

Lower Lithium Prices Pressure Outlook

The bank reduced its 2026 adjusted EBITDA estimate by 14.4% to $2.88 billion from $3.37 billion. Its 2027 estimate fell 18.4% to $2.93 billion from $3.59 billion.

Earnings per share estimates also declined. The 2026 adjusted earnings estimate dropped to $12.05 per share from $14.20. The 2027 estimate fell to $11.65 from $15.35.

These revisions reflect weaker lithium prices. China lithium carbonate prices averaged $24,810 per metric ton in the second quarter but averaged about $21,625 so far in the third quarter.

JPMorgan now expects lithium prices to remain in the low-$20-per-kilogram range, down from its previous model of the mid-$20 range. Each $1-per-kilogram change could affect Albemarle’s annual EBITDA by about $250 million.

Third-Quarter Profit Expected to Fall

JPMorgan expects third-quarter adjusted EBITDA of $668 million. This would fall from $858 million in the second quarter but rise from $226 million a year earlier.

The firm also expects lower quarterly lithium sales volume and a weaker product mix.

Meanwhile, Albemarle faces delays at the Greenbushes CGP3 plant following a June fire. The plant restarted Aug. 1, but JPMorgan now expects full production rates by the end of the first quarter of 2027.

What the Numbers Show

The sensitivity of Albemarle’s profitability to lithium pricing is acute. With each $1-per-kilogram price change impacting annual EBITDA by approximately $250 million, the shift from mid-$20s to low-$20s pricing models directly explains the multi-billion dollar downward revision in long-term EBITDA estimates. This high operating leverage means modest absolute declines in commodity prices translate into significant percentage drops in reported earnings power.

The bank said Albemarle trades near its price forecast and carries a fair valuation for a high-quality but volatile lithium producer.